Donald Trump’s herd immunity plan may result in ‘millions’ of US deaths, experts warn
President’s advisers have consulted scientists about proposals to follow controversial strategy
Senior advisers to Donald Trump have met with scientists for advice on pushing a herd immunity strategy that experts say could trigger the deaths of “millions” of Americans.
On Monday, Trump’s health chief Alex Azar and adviser Scott Atlas consulted three scientists who back the idea that the US “can quickly and safely achieve widespread immunity to the coronavirus by allowing it to spread unfettered among healthy people”, Politico reports.
Following the meeting, Health and Human Services Secretary Azar tweeted that they had “heard strong reinforcement of the Trump Administration’s strategy of aggressively protecting the vulnerable while opening schools and the workplace”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The scientists present - or as Azar described them, the “three distinguished infectious disease experts” - were Harvard University professor of medicine Martin Kulldorff, Stanford physician and epidemiologist Jay Bhattacharya, and Oxford epidemiologist Sunetra Gupta.
All three are advocates of aggressively reopening up the US economy and sidelining mass testing.
But “mainstream medical and public health experts say that seeking widespread, or herd, immunity in the manner the scientists prescribe could result in the deaths of hundreds of thousands or even millions more US residents”, Politico says.
The Covid-19 coronavirus has already claimed the lives of more than 210,000 Americans, according to latest figures.
A study published in The Lancet last month found that less than 10% of the US population had antibodies to the virus.
Centers for Disease Control and Prevention (CDC) director Dr Robert Redfield subsequently told a hearing of the Senate Health, Education, Labor and Pensions Committee that “a majority of American” were “still vulnerable to infection, serious illness and death”.
But “the idea of allowing the virus to spread uncontrollably is gaining traction in the White House”, despite experts warning that the move could have “deadly and dangerous consequences”, The Hill says.
The US Department of Health and Human Services, headed by Azar, declined to comment to Politico on whether the Trump administration is shifting to a herd immunity strategy.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joe Evans is the world news editor at TheWeek.co.uk. He joined the team in 2019 and held roles including deputy news editor and acting news editor before moving into his current position in early 2021. He is a regular panellist on The Week Unwrapped podcast, discussing politics and foreign affairs.
Before joining The Week, he worked as a freelance journalist covering the UK and Ireland for German newspapers and magazines. A series of features on Brexit and the Irish border got him nominated for the Hostwriter Prize in 2019. Prior to settling down in London, he lived and worked in Cambodia, where he ran communications for a non-governmental organisation and worked as a journalist covering Southeast Asia. He has a master’s degree in journalism from City, University of London, and before that studied English Literature at the University of Manchester.
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published
-
The week's best photos
In Pictures A cyclone's aftermath, a fearless leap, and more
By Anahi Valenzuela, The Week US Published
-
The Imaginary Institution of India: a 'compelling' exhibition
The Week Recommends 'Vibrant' show at the Barbican examines how political upheaval stimulated Indian art
By The Week UK Published
-
Does Trump have the power to end birthright citizenship?
Today's Big Question He couldn't do so easily, but it may be a battle he considers worth waging
By Joel Mathis, The Week US Published
-
Trump, Musk sink spending bill, teeing up shutdown
Speed Read House Republicans abandoned the bill at the behest of the two men
By Peter Weber, The Week US Published
-
Is Elon Musk about to disrupt British politics?
Today's big question Mar-a-Lago talks between billionaire and Nigel Farage prompt calls for change on how political parties are funded
By Sorcha Bradley, The Week UK Published
-
Will California's EV mandate survive Trump, SCOTUS challenge?
Today's Big Question The Golden State's climate goal faces big obstacles
By Joel Mathis, The Week US Published
-
'Underneath the noise, however, there's an existential crisis'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Is the United States becoming an oligarchy?
Talking Points How much power do billionaires like Elon Musk really have?
By Joel Mathis, The Week US Published
-
'It's easier to break something than to build it'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Jay Bhattacharya: another Covid-19 critic goes to Washington
In the Spotlight Trump picks a prominent pandemic skeptic to lead the National Institutes of Health
By David Faris Published